Scorpius Holdings Faces Delisting Concerns

TL;DR

SCPX might get delisted, big trouble for shareholders.

AI Summary

Scorpius Holdings, Inc. (formerly NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.) filed an 8-K on May 29, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The company, incorporated in Delaware with its principal office in Morrisville, NC, is in the pharmaceutical preparations industry.

Why It Matters

This filing indicates potential issues with Scorpius Holdings' continued listing on an exchange, which could significantly impact its stock value and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.

Key Players & Entities

• Scorpius Holdings, Inc. (company) — Registrant
• NightHawk Biosciences, Inc. (company) — Former Company Name
• HEAT BIOLOGICS, INC. (company) — Former Company Name
• May 29, 2024 (date) — Date of Earliest Event Reported

FAQ

Key Financial Figures

• $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE America

Filing Documents

• scpx_8k.htm (8-K) — 33KB
• 0001079973-24-000824.txt ( ) — 246KB
• scpx-20240529.xsd (EX-101.SCH) — 3KB
• scpx-20240529_def.xml (EX-101.DEF) — 26KB
• scpx-20240529_lab.xml (EX-101.LAB) — 36KB
• scpx-20240529_pre.xml (EX-101.PRE) — 25KB
• scpx_8k_htm.xml (XML) — 5KB

01 Notice of Delisting or

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing. As previously reported, on May 20, 2024, Scorpius Holdings, Inc. (the "Company") notified the NYSE American LLC (the "Exchange") that it was unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 by the extended filing date under Rule 12b-25 of the Securities Exchange Act of 1934. On May 21, 2024, the Company received a notice from the NYSE Regulation (the "NYSE Notice") stating that the Company is not in compliance with the continued listing standards of the Exchange because the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 (the "Form 10-Q"), which was due to be filed with the Securities and Exchange Commission (the "SEC") no later than May 20, 2024. The Company filed its delayed Form 10-Q for the period ended March 31, 2024 with the SEC on May 28, 2024. As a result, on May 29, 2024, the Company was notified by the Exchange that it has now regained compliance with Section 1007 of the NYSE American Company Guide and it will be removed from the late filers' list disseminated to data vendors and posted on the Listed Standards Filing Status page on www.nyse.com. And that the "LF" indicator posted on the Profile, Data and News pages related to each issue will be removed.

08. Shareholder

Item 5.08. Shareholder Director Nominations. To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.

01

Item 8.01. Other Events. The Company previously reported that it plans to hold its 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting") on August 2, 2024. However, the Company has determined that it will hold the 2024 Annual Meeting on July 19, 2024. The record date for determining the stockholders of record who will be entitled to vote at the 2024 Annual Meeting will remain the close of business on June 13, 2024, as previously reported. The time and location of the 2024 Annual Meeting will be as set forth in the Company's definitive proxy statement for the 2024 Annual Meeting to be filed with the Securities and Exchange Commission. Because the scheduled date of the 2024 Annual Meeting is more than 30 days prior to the anniversary of the Company's 2023 Annual Meeting of Stockholders, prior disclosed deadlines regarding the submission of stockholder proposals pursuant to Rule 14a-8 ("Rule 14a-8") under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), for the 2024 Annual Meeting are no longer applicable. The Company is hereby providing notice of certain revised deadlines for the submission of stockholder proposals in connection with the 2024 Annual Meeting. In order for a stockholder proposal, submitted pursuant to Rule 14a-8, to be considered timely for inclusion in the Company's proxy determined that June 9, 2024 is a reasonable time before the Company plans to begin printing and mailing its proxy materials. Therefore, in order for a stockholder to submit a proposal for inclusion in the Company's proxy materials for the 2024 Annual Meeting, the stockholder must comply with the requirements set forth in Rule 14a-8, including with respect to the subject matter of the proposal, and must deliver the proposal and all required documentation to the Company no later than June 9, 2024. The public announceme

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 30, 2024 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR